Alzheimer’s

NeuraLight aims to track ALS, Parkinson’s and more with an ordinary webcam

The process of diagnosing and tracking the progression of neurological disorders like Alzheimer’s is often long and imprecise, involving surveys, hospital visits and in-person observations that

Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions

Neuroglee Therapeutics, a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. The funding will be

After contentious debate, FDA approves first Alzheimer’s drug since 2003

On Monday, the US Food and Drug Administration granted approval to a keenly-watched Alzheimer’s drug, aducanumab, developed by the drugmaker Biogen. The decision to approve the drug, which was once

Neuroglee gets $2.3 million to develop digital therapeutics for neurodegenerative diseases

There are now about 50 million people with dementia globally, a number the World Health Organization expects to triple by 2050. Alzheimer’s is the leading cause of dementia and caregivers are often

Borderlands 3 bridges the gap between citizen science and blockbuster games

The Borderlands series has long offered players a chaotic loot scramble of explosive cel-shaded cartoon violence and intricately tuned shooting that leaves anything that isn’t the fun part on th

As Alzheimer’s costs soar, startups like Neurotrack raise cash to diagnose and treat the disease

As studies show that early diagnosis and preventative therapies can help prevent the onset of Alzheimer’s, startups that are working to diagnose the disease earlier are gaining more attention an

Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases

For the past 19 years, Ioannis Tarnanas, the founder and chief scientific officer at Altoida, has been developing virtual and augmented reality tools to offer predictions about the onset of mental ill

A healthcare investment fund has become one of Israel’s largest with a $660 million close

One of Israel’s largest venture capital funds is a new later-stage vehicle focused on healthcare. The aMoon investment firm launched its second vehicle in April 2018 and just announced its final

BrainQ aims to cure stroke and spinal cord injuries through mind-reader tech

Israel-based BrainQ is a new neurotech startup hoping to take on brain-computer interface (BCI) companies Kernel and Neuralink. But it's early days in this industry, including for BrainQ, which plans

A new brain health app from Neurotrack warns users of memory decline

A Redwood City, Calif. startup called Neurotrack Technologies Inc. has created a brain health app that is helping scientists unravel the mysteries of memory, and work to find a cure for Alzheimer&#8

Bryan Johnson invests $100 million in Kernel to unlock the power of the human brain

Earlier this year, former Braintree founder Bryan Johnson publicly announced his plans to forge Kernel, a company with the sole purpose of building hardware and software to augment human intelligence.

Ybrain Raises $3.5M To Fund Trials Of Its Wearable For Alzheimer’s Patients

Ybrain, a Korean startup that makes wearables for Alzheimer’s patients, announced today that it has raised $3.5 million in Series A funding led by Stonebridge Capital, bringing its total raised so f